Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis
- PMID: 17973194
- DOI: 10.1007/s10585-007-9110-x
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis
Abstract
The advent of microarray tools has generated a massive amount of gene expression data. These data have greatly enhanced our understanding of the biology of breast cancer metastasis and provide a way to improve the prediction of the metastatic potential of breast tumours. Gene-expression profiling has highlighted the molecular heterogeneity of mammary tumours and contributed to the identification of a new molecular classification of breast cancers. In addition, several molecular signatures predicting the likelihood of distant metastases for breast cancer patients have been characterized. Further reports have described gene expression profiles associated with specific metastatic phenotypes, including the organ preference of breast cancer metastasis. Here we review the major studies that had important impacts on the understanding of breast cancer metastasis. We also discuss the future challenges in this research field and the special issues that still need to be examined.
Similar articles
-
First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.Aging (Albany NY). 2020 May 24;12(11):10162-10179. doi: 10.18632/aging.103336. Epub 2020 May 24. Aging (Albany NY). 2020. PMID: 32452826 Free PMC article.
-
[Prognostic molecular classification of breast cancers based on gene expression profiling].Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533740 Chinese.
-
A six-gene signature predicting breast cancer lung metastasis.Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436. Cancer Res. 2008. PMID: 18676831
-
Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.Semin Radiat Oncol. 2008 Apr;18(2):105-14. doi: 10.1016/j.semradonc.2007.10.007. Semin Radiat Oncol. 2008. PMID: 18314065 Review.
-
Clinical and molecular complexity of breast cancer metastases.Semin Cancer Biol. 2015 Dec;35:85-95. doi: 10.1016/j.semcancer.2015.08.009. Epub 2015 Aug 28. Semin Cancer Biol. 2015. PMID: 26319607 Review.
Cited by
-
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.Br J Cancer. 2010 Aug 10;103(4):524-31. doi: 10.1038/sj.bjc.6605750. Epub 2010 Jul 20. Br J Cancer. 2010. PMID: 20648017 Free PMC article.
-
Prediction of breast cancer metastasis by genomic profiling: where do we stand?Clin Exp Metastasis. 2009;26(6):547-58. doi: 10.1007/s10585-009-9254-y. Epub 2009 Mar 24. Clin Exp Metastasis. 2009. PMID: 19308665 Free PMC article. Review.
-
Intrinsic cancer subtypes--next steps into personalized medicine.Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub 2015 Jan 14. Cell Oncol (Dordr). 2015. PMID: 25586691 Review.
-
Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved.Oncol Lett. 2011 Sep 1;2(5):831-838. doi: 10.3892/ol.2011.353. Epub 2011 Jul 5. Oncol Lett. 2011. PMID: 22866136 Free PMC article.
-
Application of Biostatistics and Bioinformatics Tools to Identify Putative Transcription Factor-Gene Regulatory Network of Ankylosing Spondylitis and Sarcoidosis.Commun Stat Theory Methods. 2009 Jan 1;38(18):3326-3338. doi: 10.1080/03610920902898472. Commun Stat Theory Methods. 2009. PMID: 20037664 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical